Biophytis starts Phase II/III Covid-19 trial of Sarconeos in Belgium
Biotechnology firm Biophytis has started enrolment and dosing of patients in a Phase II/III clinical...
Biophytis and SGS partner to test Sarconeos in Covid-19 patients
French biotech firm Biophytis will assess its Sarconeos (BIO101) drug as a treatment for respiratory...
UCB reports positive data from BE READY trial of bimekizumab
UCB has reported positive results from the Phase III BE READY clinical trial of its...
Themis Bioscience and CEPI trial Lassa fever vaccine
Themis Bioscience and the Coalition for Epidemic Preparedness Innovations (CEPI) have commenced a Phase I...
UCB’s trial of bimekizumab in psoriasis patients meets goals
UCB has announced that the Phase III BE VIVID clinical trial of its bimekizumab met...
Vaccitech begins Phase IIb universal flu vaccine trial in Belgium
UK-based Vaccitech has started treating patients with influenza A vaccine MVA-NP+M1 (VTP-100) in a Phase...
MorphoSys and Galapagos launch Phase II atopic dermatitis trial
MorphoSys and Galapagos have commenced a Phase II clinical trial, in alliance with Novartis Pharma,...
OSE Immunotherapeutics to study cancer drug in France and Belgium
OSE Immunotherapeutics has secured authorisation from the French and Belgian regulatory authorities to conduct a...
argenx begins dosing in Phase III myasthenia gravis trial
Biotechnology company argenx has started dosing patients in a Phase III clinical trial of its...
FluGen doses first subject in new study of M2SR for influenza
FluGen has dosed the first subject in a new clinical trial evaluating the M2SR vaccine...